Recent Event

<>

November 14, 2017

New York, NY

HBS Healthcare Alumni Association

Panelist : Norman Shelby

Real Endpoints LLC

Immuno-oncology treatments have provided renewed hope to cancer patients. Combination treatments bring the promise of increased efficacy with manageable side effects. Come hear from experts about what the future may bring. 

Moderator Norman Selby, Board of Trustees at Memorial Sloan Kettering, Executive Chairman of RealEndpoints and PAIGE.AI, former Senior Partner at McKinsey.

Panelists: Sophie Opdyke, VP, Immuno-Oncology Lead, Global Commercial Development at Pfizer Umer Raffat, Managing Director at Evercore ISI Peter Bach, Director, Center for Health Policy and Outcomes at MSK.

view event >

Recent Events

October 2, 2019 1:15pm

San Diego, CA

Roger Longman

Real Endpoints

Real Endpoints Founder, Roger Longman, is looking forward to leading a robust discussion focused on solutions to creating access to cell and gene therapies — solutions that work for both payers and biopharma.

view event >

May 31, 2019

Waldorf Astoria Chicago Hotel

5th Annual Immuno-Oncology BD&L and Investment Forum

Speaker: Roger Longman

Real Endpoints

Taking place on the first day of ASCO, the 5th Annual Immuno-Oncology BD&L and Investment Forum is designed to bring together thought leaders from cancer research institutes, patient advocacy groups, pharma and biotech to facilitate partnering, funding and investment. We expect around 250 delegates and about 30 presentations by listed and private biotechnology companies seeking licensing & investment. Numerous networking opportunities available via an online one-to-one meeting system with dedicated meeting facilities to make the event more transactional.

May 14, 2019 9:30am ET

Financial District, New York, NY

Panelist: Jeff Berkowitz

Real Endpoints

PANEL DISCUSSION I: Impact of Pricing and Policy on the Next Decade of Therapeutic Innovation

view event >

March 25, 2019 3:20pm

San Diego Convention Center, CA

Jane Barlow, MD, MPH, MBA

Real Endpoints

Innovative and novel financing and reimbursement strategies may be needed to support sustainable patient access to these new treatments. During this session, managed care and provider strategies for addressing gene therapy will be explored.

view event >

March 25, 2019 4:20pm

San Diego Convention Center, CA

Jane Barlow, MD, MPH, MBA

Real Endpoints

The potential for gene therapy to transform the treatment of a wide variety of health conditions has important implications for many stakeholders. During this panel discussion, participants will have the opportunity to hone in on pressing issues raised throughout the conference and discuss these issues with a panel of experts with varying backgrounds, including both clinical and managed care perspectives.

view event >

February 12, 2019 1:30 pm ET

New York Marriott Marquis

Panelist: Roger Longman

Real Endpoints

Departure from traditional dosage-based models makes it difficult for therapy developers, payers, patients, and investors to plan for a new therapy’s rollout and breadth of patient access. This session will explore the early lessons from current value-based agreements to explain the payers’ expectations for future models of reimbursing treatments based on outcomes versus delivery.

view event >